DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
β–Lactam TRPM8 Antagonist RGM8-51 Displays Antinociceptive Activity in Different Animal Models
Transient receptor potential melastatin subtype 8 (TRPM8) is a cation channel extensively
expressed in sensory neurons and implicated in different painful states. However, the effectiveness
of TRPM8 modulators for pain relief is still a matter of discussion, since structurally diverse mod-
ulators lead to different results, depending on the animal pain model. In this work, we described
the antinociceptive activity of a β–lactam derivative, RGM8-51, showing good TRPM8 antagonist
activity, and selectivity against related thermoTRP channels and other pain-mediating receptors. In
primary cultures of rat dorsal root ganglion (DRG) neurons, RGM8-51 potently reduced menthol-
evoked neuronal firing without affecting the major ion conductances responsible for action potential
generation. This compound has in vivo antinociceptive activity in response to cold, in a mouse model
of oxaliplatin-induced peripheral neuropathy. In addition, it reduces cold, mechanical and heat
hypersensitivity in a rat model of neuropathic pain arising after chronic constriction of the sciatic
nerve. Furthermore, RGM8-51 exhibits mechanical hypersensitivity-relieving activity, in a mouse
model of NTG-induced hyperesthesia. Taken together, these preclinical results substantiate that this
TRPM8 antagonist is a promising pharmacological tool to study TRPM8-related disease., This research was funded by the Spanish Ministerio de Ciencia y Universidades (MICYU-
FEDER, RTI2018-097189-C2-1 to A.F.-M. and A.F.-C., and RTI2018-097189-C2-2 to R.G.-M.), Comu-
nidad de Madrid (IND2017/BMD7673 to R.G.-M.) and the Spanish National Research Council (CSIC,
201980E030 to R.G.-M.), and Universidad Complutense de Madrid (PR75/18-21593, FEI20/35 and
PID2019-109155RB-I00 to A.R.A.)., Peer reviewed